Recce Pharmaceuticals Ltd

NEW
FRA:R9Q (Australia)  
€ 0.25 +0.057 (+29.53%) Jul 31
At Loss
Market Cap:
€ 65.23M ($ 75.25M)
Enterprise V:
€ 71.53M ($ 82.53M)
Volume:
5.00K
Avg Vol (2M):
5.00K
Trade In:

Recce Pharmaceuticals Ltd (FRA:R9Q) Dividend

Recce Pharmaceuticals Ltd (FRA:R9Q) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:R9Q Dividend

Does Recce Pharmaceuticals Ltd (FRA:R9Q) pay a dividend?

Recce Pharmaceuticals Ltd (FRA:R9Q) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Recce Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Recce Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -16.8% over the past 3 years.

What are dividend-paying alternatives to Recce Pharmaceuticals Ltd?

For dividend-paying alternatives in Recce Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.